Skip to main content

Medication leaflets

ATC
Veterinary

Română
English
Deutsch

Search for medicines for human use

Search for medicines for human use

Medication leaflets
Index of medicine substances
Letter G | page 2 | drug substances index

Index of medicine substances

Letter G · page 2

72

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gilteritinib

Indicated for: cancer

L01EX13 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors
Ginkgo biloba

Indicated for: cognitive disorders; peripheral vascular disease

N06DX02 Nervous system | Anti-dementia drugs | Other anti-dementia drugs
Ginkgo biloba + panax ginseng

Indicated for: asthenia; mild memory and concentration complaints

N06BXN3 Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics
Givosiran

Indicated for: acute hepatic porphyria

A16AX16 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products
Glasdegib

Indicated for: cancer

L01XJ03 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Hedgehog pathway inhibitors
Glatiramer acetate

Indicated for: multiple sclerosis

L03AX13 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants
Glecaprevir + pibrentasvir

Indicated for: chronic hepatitis C

J05AP57 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections
Glibenclamide

Indicated for: type 2 diabetes mellitus

A10BB01 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glibenclamide + metformin

Indicated for: type 2 diabetes mellitus

A10BD02 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs
Gliclazide

Indicated for: type 2 diabetes mellitus

A10BB09 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glimepiride

Indicated for: type 2 diabetes mellitus

A10BB12 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glipizide

Indicated for: type 2 diabetes mellitus

A10BB07 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Gliquidone

Indicated for: type 2 diabetes mellitus

A10BB08 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Glofitamab

Indicated for: hematologic malignancies

L01FX28 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates
Glucagon

Indicated for: hypoglycemia

H04AA01 Systemic hormonal preparations, excluding sex hormones and insulins | Glycogenolytic hormones
Glucarpidase

Indicated for: methotrexate toxicity

V03AF09 Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment
Glucosamine

Indicated for: osteoarthritis; degenerative joint disorders

M01AX05 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids
Glucose

Indicated for: hypoglycemia

B05BA03 Blood and blood forming organs | I.v. solutions | Solutions for parenteral nutrition
Glucose + sodium chloride + potassium chloride

Indicated for: rehydration; fluid and electrolyte imbalance

B05BB02 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance
Glycerol

Indicated for: constipation

A06AX01 Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Other drugs for constipation
Glycerol phenylbutyrate

Indicated for: urea cycle disorders

A16AX09 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products
Glycerophosphate

Indicated for: mineral deficiency; mineral supplementation

B05XA14 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions
Glycopyronium + formoterol

Indicated for: chronic obstructive pulmonary disease

R03AL07 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
Glycopyrronium bromide

Indicated for: chronic obstructive pulmonary disease

R03BB06 Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics
Glycopyrronium bromide + neostigmine methylsulfate

Indicated for: reversal of neuromuscular blockade

A03AB02 Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds
Glycosides from Senna

Indicated for: constipation

A06AB06 Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Contact laxatives
Goldenrod herb + orthosiphon leaf + restharrow root

Indicated for: urinary tract flushing; mild urinary infections; urinary stones

G04BXN1 Genito urinary system and sex hormones | Urologicals | Urologicals | Other urologicals
Golimumab

Indicated for: autoimmune inflammatory diseases

L04AB06 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors
Goserelin

Indicated for: prostate cancer; breast cancer; endometriosis

L02AE03 Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues
Granisetron

Indicated for: chemotherapy-induced nausea and vomiting

A04AA02 Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists

‹ Previous page

1
2
3

Copyright © prospecte.ro 2019-2026. All rights reserved.

We do not guarantee the accuracy, completeness, or timeliness of the displayed data.

The information on this site is for informational purposes only and does not replace the advice of a doctor or pharmacist.

For diagnosis, treatment, dosage, or side effects, consult your doctor, pharmacist, or the official leaflet.

Official sources

Sources:

CNAS
ANMDMR
EMA
ICBMV

About
Editorial policy
Methodology
Corrections
Contact